DHFR and acute lymphoblastic leukemia: Moreover, one of the components of ALL treatment, methotrexate (MTX), acts by inhibiting dihydrofolate reductase, which is critical for the reduction in methyltetrahydrofolate and for methylation during DNA replication, which in turn directly reduces cell proliferation32.